Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diatrizoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.87 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diatrizoic Acid SCHEMBL4728330 | 0.95 | SMN1; SMN2 (0.78) | SMN1; SMN2LMNAKDM4E | |
| Diatrizoic Acid SCHEMBL2501947 | 0.94 | SMN1; SMN2 (0.97) | SMN1; SMN2LMNAKDM4ECYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL720469 | 0.93 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAKDM4ECYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL1685085 | 0.93 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAKDM4ECYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL107036 | 0.93 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAKDM4ECYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL468613 | 0.92 | SMN1; SMN2 (0.97) | SMN1; SMN2LMNAKDM4ECYP1A2TSHR | |
| Iothalamic Acid SCHEMBL29488709 | 0.85 | SMN1; SMN2 (0.84) | SMN1; SMN2LMNAKDM4ECYP1A2TSHR | |
| Iothalamic Acid SCHEMBL180546 | 0.85 | SMN1; SMN2 (0.84) | SMN1; SMN2LMNAKDM4ECYP1A2TSHR | |
| Iothalamic Acid SCHEMBL48785 | 0.85 | SMN1; SMN2 (0.84) | SMN1; SMN2LMNAKDM4ECYP1A2TSHR | |
| Iothalamic Acid SCHEMBL3060866 | 0.84 | SMN1; SMN2 (0.83) | SMN1; SMN2LMNAKDM4ECYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 550 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4732418-A2 | DISCHARGE CONTROL FOR POWER PROCESSING AND TIME-VARYING VOLTAGE PROFILE GENERATION | The Regents Of The University Of Michigan (US) | 2026-04-29 | — | — | EP | claimed |
| US-20250301329-A1 | DEVICES AND METHODS FOR EMBEDDED SUBSCRIBER IDENTITY MODULE PROVISIONING | HAND HELD PRODUCTS, INC. | 2025-09-25 | — | — | US | claimed |
| EP-4622316-A1 | DEVICES AND METHODS FOR EMBEDDED SUBSCRIBER IDENTITY MODULE PROVISIONING | Hand Held Products, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| EP-4543498-A2 | COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING | Suntec Medical, Inc. (US) | 2025-04-30 | — | — | EP | claimed |
| US-20250121100-A1 | COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING | SUNTEC MEDICAL INC (US) | 2025-04-17 | — | — | US | claimed |
| CN-119698306-A | Compositions and methods for diagnostic imaging | 欣扬生医股份有限公司 | 2025-03-25 | — | — | CN | claimed |
| WO-2024264049-A2 | DISCHARGE CONTROL FOR POWER PROCESSING AND TIME-VARYING VOLTAGE PROFILE GENERATION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-12-26 | — | — | WO | claimed |
| US-20240343483-A1 | DEVICE AND METHOD FOR PLACING RACKS | KIA CORPORATION (KR) | 2024-10-17 | — | — | US | claimed |
| US-12053880-B2 | Mobile robot platform | BROETJE-AUTOMATION GMBH (DE) | 2024-08-06 | — | — | US | claimed |
| CN-116094992-B | Message forwarding method, storage medium and device based on worksheet scene | 中电信数智科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-108535722-B | Radar reference azimuth calibration device | 中国人民解放军陆军炮兵防空兵学院郑州校区 | 2023-11-03 | — | — | CN | claimed |
| CN-115024839-B | Orthodontic archwire error rate evaluation method based on normalized bending point angular distance ratio | 哈尔滨理工大学 | 2023-10-27 | — | — | CN | claimed |
| WO-2023187235-A1 | FOUNDATION FOR WIND GENERATOR TOWERS AND BUILDING METHOD OF SAID FOUNDATION | MS TECHNO RDITECH SL (ES) | 2023-10-05 | — | — | WO | claimed |
| CN-113839392-B | Power grid reactive voltage robust optimization method considering distributed new energy random output | 华北电力大学（保定） | 2023-07-18 | — | — | CN | claimed |
| US-20230220487-A1 | MOLECULAR MARKERS AND METHODS FOR SAMPLE ANALYSIS VIA MASS SPECTROMETRY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-07-13 | — | — | US | claimed |
| WO-2023094450-A1 | CONTROL SYSTEM AND METHOD FOR A VEHICLE USING POWERLINE COMMUNICATION, PLC. | ZF FRIEDRICHSHAFEN AG (DE) | 2023-06-01 | — | — | WO | claimed |
| CN-116094992-A | Message forwarding method, storage medium and device based on worksheet scene | 中电信数智科技有限公司 | 2023-05-09 | — | — | CN | claimed |
| WO-2022243964-A1 | ARRANGEMENT OF ELECTRONIC ELEMENTS TO OPTIMIZE USER MANAGEMENT IN THE GAMING BET MARKET | PINERO MAS ISRAEL (ES) | 2022-11-24 | — | — | WO | claimed |
| US-20220188922-A1 | SYSTEM AND METHOD OF PROVIDING A BENEFIT | KASHABLE LLC (US) | 2022-06-16 | — | — | US | claimed |
| CN-108537055-B | Privacy budget allocation and data release method and system for data query privacy protection | 南京邮电大学 | 2022-04-05 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250121100-A1 | COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING | ABCB4, C5, APOB | SMN1; SMN2 2359/4885LMNA 793/4885KDM4E 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.